SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

UPLOAD Filing

Spring Valley Acquisition Corp. III
Date: Aug. 13, 2025 · CIK: 0002074850 · Accession: 0000000000-25-008495

Related Party / Governance Regulatory Compliance Financial Reporting

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-289294

Date
August 13, 2025
Author
Division of
Form
UPLOAD
Company
Spring Valley Acquisition Corp. III

Letter

Re: Spring Valley Acquisition Corp. III Registration Statement on Form S-1 Filed August 6, 2025 File No. 333-289294 Dear Christopher Sorrells:

August 13, 2025

Christopher Sorrells Chief Executive Officer Spring Valley Acquisition Corp. III 2100 McKinney Ave., Suite 1675 Dallas, TX 75201

We have reviewed your registration statement and have the following comment.

Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe a comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response.

After reviewing any amendment to your registration statement and the information you provide in response to this letter, we may have additional comments.

Registration Statement on Form S-1 Proposed Business Sponsor Information, page 13

1. We note your response to prior comment 7. Please state the current amount of interest Christopher Sorrells has in the sponsor. See Item 1603(a)(7) of Regulation S-K. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Refer to Rules 460 and 461 regarding requests for acceleration. Please allow adequate time for us to review any amendment prior to the requested effective date of the registration statement. August 13, 2025 Page 2

Please contact Christine Torney at 202-551-3652 or Daniel Gordon at 202-551-3486 if you have questions regarding comments on the financial statements and related matters. Please contact Doris Stacey Gama at 202-551-3188 or Chris Edwards at 202-551- 6761 with any other questions.

Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Jason Simon, Esq.

Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 August 13, 2025

Christopher Sorrells
Chief Executive Officer
Spring Valley Acquisition Corp. III
2100 McKinney Ave., Suite 1675
Dallas, TX 75201

 Re: Spring Valley Acquisition Corp. III
 Registration Statement on Form S-1
 Filed August 6, 2025
 File No. 333-289294
Dear Christopher Sorrells:

 We have reviewed your registration statement and have the following
comment.

 Please respond to this letter by amending your registration statement
and providing
the requested information. If you do not believe a comment applies to your
facts and
circumstances or do not believe an amendment is appropriate, please tell us why
in your
response.

 After reviewing any amendment to your registration statement and the
information
you provide in response to this letter, we may have additional comments.

Registration Statement on Form S-1
Proposed Business
Sponsor Information, page 13

1. We note your response to prior comment 7. Please state the current
amount of interest
 Christopher Sorrells has in the sponsor. See Item 1603(a)(7) of
Regulation S-K.
 We remind you that the company and its management are responsible for
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action
or absence
of action by the staff.

 Refer to Rules 460 and 461 regarding requests for acceleration. Please
allow adequate
time for us to review any amendment prior to the requested effective date of
the registration
statement.
 August 13, 2025
Page 2

 Please contact Christine Torney at 202-551-3652 or Daniel Gordon at
202-551-3486
if you have questions regarding comments on the financial statements and
related
matters. Please contact Doris Stacey Gama at 202-551-3188 or Chris Edwards at
202-551-
6761 with any other questions.

 Sincerely,

 Division of
Corporation Finance
 Office of Life
Sciences
cc: Jason Simon, Esq.
</TEXT>
</DOCUMENT>